In vivo model of intracranial stent implantation: A pilot study to examine the histological response of cerebral vessels after randomized implantation of heparin-coated and uncoated endoluminal stents in a blinded fashion

Journal of Neurosurgery

Volumn 98, Issue 3, 2003, Pages 544-553

  Levy, Elad I ^b   Boulos, Alan S ^b   Hanel, Ricardo A ^b   Tio, Fermin O ^b   Alberico, Ronald A ^b   Fronckowiak, Mary Duffy ^b   Nemes, Balazs ^b   Paciorek, Ann Marie ^b   Guterman, Lee R ^b   Hopkins, L Nelson ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NONE

Author keywords

Basilar artery; Dog; Intracranial stent

Indexed keywords

HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; BASILAR ARTERY; BLOOD VESSEL INJURY; BRAIN ANGIOGRAPHY; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DOG; FOLLOW UP; HISTOLOGY; HISTOPATHOLOGY; IMPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; STENT;

EID: 0037373499     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.98.3.0544     Document Type: Article

References (51)

1. Ahn YK, Jeong MH, Kim JW, et al: Preventive effects of the heparin-coated stent on restenosis in the porcine model. Catheter Cardiovasc Interv 48:324-330, 1999
2. Al-Mubarak N, Gomez CR, Vitek JJ, et al: Stenting of symptomatic stenosis of the intracranial internal carotid artery. AJNR 19:1949-1951, 1998
3. American Heart Association: Heart and Stroke Facts: 1997 Statistical Supplement. Dallas: American Heart Association, 1998
4. Andres V: Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis. Int J Mol Med 2:81-89, 1998
5. Anonymous: Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 29:1389-1392, 1998
6. Anonymous: 1993 Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 202:229-249, 1993
7. Ausman JI, Shrontz CE, Pearce JE, et al: Vertebrobasilar insufficiency. A review. Arch Neurol 42:803-808, 1985
8. Axel DI, Kunert W, Goggelmann C, et al: Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96:636-645, 1997
9. Carter AJ, Laird JR, Farb A, et al: Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 24:1398-1405, 1994
10. Chan P, Patel M, Betteridge L, et al: Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis. Lancet 341:341-342, 1993
11. Chimowitz MI, Kokkinos J, Strong J, et al: The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 45: 1488-1493, 1995
12. Congress of the United States: Animal Welfare Act, Regulations, and Standards. (http://www.aphis.usda.gov/ac/awa.html) [Accessed 2 January 2003]
13. De Scheerder I, Wang K, Wilczek K, et al: Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents. Circulation 95:1549-1553, 1997
14. Derdeyn CP, Cross DT III, Moran CJ, et al: Reversal of focal misery perfusion after intracranial angioplasty: case report. Neurosurgery 48:436-440, 2001
15. Fischell TA, Virmani R: Intracoronary brachytherapy in the porcine model: a different animal. Circulation 104:2388-2390, 2001
16. Geary RL: Restenosis Following Arterial Reconstruction. (http: //www.vascularweb.org/doc/137) [Accessed 2 January 2003]
17. Geary RL, Nikkari ST, Wagner WD, et al: Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg 27:96-108, 1998
18. Geary RL, Williams JK, Golden D, et al: Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. A non-human primate model of restenosis. Arterioscler Thromb Vasc Biol 16:34-43, 1996
19. Gomez CR, Misra VK, Campbell MS, et al: Elective stenting of symptomatic middle cerebral artery stenosis. AJNR 21:971-973, 2000
20. Gomez CR, Misra VK, Liu MW, et al: Elective stenting of symptomatic basilar artery stenosis. Stroke 31:95-99, 2000
21. Hardhammar PA, van Beusekom HM, Emanuelsson HU, et al: Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93:423-430, 1996
22. Herdeg C, Oberhoff M, Baumbach A, et al: Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J Am Coll Cardiol 35:1969-1976, 2000
23. Hopkins LN, Budny JL: Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg 70:207-211, 1989
24. Hopkins LN, Budny JL, Castellani D: Extracranial-intracranial arterial bypass and basilar artery ligation in the treatment of giant basilar artery aneurysms. Neurosurgery 13:189-194, 1983
25. Hopkins LN, Martin NA, Hadley MN, et al: Vertebrobasilar insufficiency. Part 2. Microsurgical treatment of intracranial vertebrobasilar disease. J Neurosurg 66:662-674, 1987
26. Komowski R, Hong MK, Tio FO, et al: A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis. Coron Artery Dis 8: 293-298, 1997
27. Lang IM, Marsh JJ, Konopka RG, et al: Factors contributing to increased vascular fibrinolytic activity in mongrel dogs. Circulation 87:1990-2000, 1993
28. Lang J: Clinical Anatomy of Brain Stem Vessels. New Haven: Miles Pharmaceutical, 1983
29. Levy EI, Firlik AD, Wisniewski S, et al: Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intraarterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 45:539-548, 1999
30. Levy EI, Horowitz MB, Koebbe CJ, et al: Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 48:1215-1223, 2001
31. Lieber BB, Stancampiano AP, Wakhloo AK: Alteration of hemodynamics in aneurysm models by stenting: influence of stent porosity. Ann Biomed Eng 25:460-469, 1997
32. Lopes DK, Ringer AJ, Boulos AS, et al: Patency of arterial branches crossed by intracranial stents: fate of the "jailed" artery. J Neurosurg 94:169A, 2001 (Abstract)
33. Matsumoto Y, Shimokawa H, Morishige K, et al: Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries. J Cardiovasc Pharmacol 39:513-522, 2002
34. Oesterle SN, Whitboum R, Fitzgerald PJ, et al: The stent decade: 1987 to 1997. Stanford Stent Summit faculty. Am Heart J 136:578-599, 1998
35. Pauletto P, Sartore S, Pessina AC: Smooth-muscle-cell proliferation and differentiation in neointima formation and vascular restenosis. Clin Sci (Lond) 87:467-479, 1994
36. Qureshi AI, Luft AR, Sharma M, et al: Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I - Pathophysiological and pharmacological features. Neurosurgery 46:1344-1359, 2000
37. Rasmussen PA, Perl J II, Barr JD, et al: Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 92:771-778, 2000
38. Riessen R, Wight TN, Pastore C, et al: Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 93: 1141-1147, 1996
39. Rogers C, Edelman ER, Simon DI: A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 95:10134-101349, 1998
40. Rogers C, Kamovsky MJ, Edelman ER: Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 88:1215-1221, 1993
41. Schwartz SM, deBlois D, O'Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 77:445-465, 1995
42. Sousa JE, Costa MA, Abizaid A, et al: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103:192-195, 2001
43. Sousa JE, Costa MA, Abizaid AC, et al: Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104:2007-2011, 2001
44. Suzuki T, Kopia G, Hayashi S, et al: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104:1188-1193, 2001
45. Taylor AJ, Gorman PD, Farb A, et al: Long-term coronary vascular response to (32)P beta-particle-emitting stents in a canine model. Circulation 100:2366-2372, 1999
46. Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55:490-497, 2000
47. Vrolix MC, Legrand VM, Reiber JH, et al: Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol 86:385-389, 2000
48. Wainwright CL, Miller AM, Wadsworth RM: Inflammation as a key event in the development of neoinfima following vascular balloon injury. Clin Exp Pharmacol Physiol 28:891-895, 2001
49. Wakhloo AK, Lanzino G, Lieber BB, et al: Stents for intracranial aneurysms: the beginning of a new endovascular era? Neurosurgery 43:377-379, 1998
50. Wakhloo AK, Tio FO, Lieber BB, et al: Self-expanding nitinol stents in canine vertebral arteries: hemodynamics and tissue response. AJNR 16:1043-1051, 1995
51. Welt FG, Woods TC, Edelman ER: Oral heparin prevents neointimal hyperplasia after arterial injury: inhibitory potential depends on type of vascular injury. Circulation 104:3121-3124, 2001